2nd Quarter - Report — IPOLICY SOLUTIONS for TWIST BIOSCIENCE CORPORATION (2020)

Firm

IPOLICY SOLUTIONS

Client

TWIST BIOSCIENCE CORPORATION

Income

$30,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020/ Senate: No bill number

Lobbyist	Covered position, as disclosed
MEGAN ANDERSON BROOKS	—
JENNIFER RACHEL LEIB	Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Bills named: H.R. 2740 (116th)

Medical/Disease Research/Clinical Labs MED

Synthetic positive controls for COVID-19

Lobbyist	Covered position, as disclosed
MEGAN ANDERSON BROOKS	—
JENNIFER RACHEL LEIB	Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Science/Technology SCI

H.R.4373 - Engineering Biology Research and Development Act of 2019  S. 3734, Bioeconomy Development Act of 2020 Biosecurity standards American competitiveness

Lobbyist	Covered position, as disclosed
MEGAN ANDERSON BROOKS	—
JENNIFER RACHEL LEIB	Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 4373 (116th), S. 3734 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.